• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[心脏法布里病患者的终末期心脏表现及尸检结果]

[End-stage cardiac manifestations and autopsy findings in patients with cardiac fabry disease].

作者信息

Teraguchi Hiroyuki, Takenaka Toshihiro, Yoshida Aichi, Taguchi Syuhei, Ninomiya Kenjiro, Yoshida Hiroki, Horinouchi Michiko, Yonezawa Suguru, Nakao Shoichiro, Minagoe Shinichi, Tei Shuwa

出版信息

J Cardiol. 2004 Feb;43(2):98-9.

PMID:15046052
Abstract

BACKGROUND

Fabry disease is an X-linked recessive disorder resulting from a deficiency of alpha-galactosidase A with multi-organ dysfunction. Patients with manifestations limited to the heart have been reported recently as a disease variant. We have previously reported a 3% prevalence of this cardiac variant in men with left ventricular hypertrophy, which we designated cardiac Fabry disease. The purposes of the current study were to evaluate the end-stage cardiac manifestations and autopsy findings in patients with cardiac Fabry disease.

METHODS AND RESULTS

We evaluated five autopsied male patients with cardiac Fabry disease. One died of ventricular fibrillation and four of heart failure. Electrocardiograms obtained at hospitalization revealed the presence of conduction abnormalities and nonsustained ventricular tachycardia. Echocardiograms and autopsy findings showed the presence of left ventricular hypertrophy in all patients. Localized thinning of the basal posterior wall of the left ventricle was detected in four patients who died of heart failure. All patients had severe left ventricular dysfunction. Histologically, myocardial cells showed glycosphingolipid accumulation in all of the patients but no accumulation was observed in other organs or in systemic vascular endothelial cells.

CONCLUSIONS

Severe left ventricular dysfunction, conduction disturbances and ventricular arrhythmias occur in end-stage cardiac Fabry patients. Furthermore, left ventricular hypertrophy commonly associated with thinning of the base of the left ventricular posterior wall is present. The accumulation of glycosphingolipids can be observed in myocardial cells but not in other organs.

摘要

背景

法布里病是一种X连锁隐性疾病,由α-半乳糖苷酶A缺乏导致多器官功能障碍。最近有报道称,有一种疾病变体,其表现仅限于心脏。我们之前报道过,在左心室肥厚男性中,这种心脏变体的患病率为3%,我们将其命名为心脏型法布里病。本研究的目的是评估心脏型法布里病患者的终末期心脏表现及尸检结果。

方法与结果

我们评估了5例经尸检确诊的心脏型法布里病男性患者。1例死于心室颤动,4例死于心力衰竭。住院时的心电图显示存在传导异常和非持续性室性心动过速。超声心动图和尸检结果显示,所有患者均有左心室肥厚。4例死于心力衰竭的患者检测到左心室基底后壁局部变薄。所有患者均有严重的左心室功能障碍。组织学检查显示,所有患者的心肌细胞均有糖鞘脂蓄积,但在其他器官或全身血管内皮细胞中未观察到蓄积。

结论

心脏型法布里病终末期患者会出现严重的左心室功能障碍、传导紊乱和室性心律失常。此外,常伴有左心室后壁基底变薄的左心室肥厚也存在。糖鞘脂蓄积可在心肌细胞中观察到,但在其他器官中未观察到。

相似文献

1
[End-stage cardiac manifestations and autopsy findings in patients with cardiac fabry disease].[心脏法布里病患者的终末期心脏表现及尸检结果]
J Cardiol. 2004 Feb;43(2):98-9.
2
Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.心脏法布里病患者的终末期心脏表现:一项心电图、超声心动图及尸检研究
J Cardiol. 2008 Feb;51(1):50-9. doi: 10.1016/j.jjcc.2007.12.001. Epub 2008 Feb 6.
3
Fabry disease.法布里病
J Echocardiogr. 2017 Dec;15(4):151-157. doi: 10.1007/s12574-017-0340-x. Epub 2017 Jul 3.
4
An atypical variant of Fabry's disease in men with left ventricular hypertrophy.患有左心室肥厚的男性中的一种非典型法布里病变体。
N Engl J Med. 1995 Aug 3;333(5):288-93. doi: 10.1056/NEJM199508033330504.
5
Severe left ventricular hypertrophy in Anderson-Fabry disease.安德森-法布里病中的严重左心室肥厚。
Heart. 2004 Oct;90(10):1136. doi: 10.1136/hrt.2003.031666.
6
Fabry disease in patients with hypertrophic cardiomyopathy (HCM).肥厚型心肌病(HCM)患者中的法布里病。
Z Kardiol. 2002 Dec;91(12):992-1002. doi: 10.1007/s00392-002-0870-7.
7
Fabry's disease presenting as ventricular tachycardia and left ventricular 'hypertrophy'.以室性心动过速和左心室“肥厚”为表现的法布里病。
Eur J Echocardiogr. 2008 Sep;9(5):697-9. doi: 10.1093/ejechocard/jen132. Epub 2008 Apr 4.
8
Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease.二维斑点追踪作为一种无创工具用于鉴定法布里病心肌纤维化。
Eur Heart J. 2013 Jun;34(21):1587-96. doi: 10.1093/eurheartj/eht098. Epub 2013 Mar 21.
9
The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease.法布里病中心脏形态和功能表现的变化:对疾病病程的潜在影响。
Eur Heart J. 2005 Jun;26(12):1221-7. doi: 10.1093/eurheartj/ehi143. Epub 2005 Feb 23.
10
Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.酶替代疗法对安德森-法布里病心肌病的影响:阿加糖酶α的一项随机、双盲、安慰剂对照临床试验。
Heart. 2008 Feb;94(2):153-8. doi: 10.1136/hrt.2006.104026. Epub 2007 May 4.

引用本文的文献

1
Different Phenotypes of Anderson-Fabry Disease Identified with Cardiac Magnetic Resonance Imaging in a Family with the Same Late-Onset Mutation.心脏磁共振成像在一个具有相同迟发性突变的家系中鉴定出不同表型的安德森-法布里病。
Am J Case Rep. 2020 Oct 29;21:e925631. doi: 10.12659/AJCR.925631.
2
Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy.左心室几何形态和血压作为法布里心肌病不良进展的预测指标
PLoS One. 2015 Nov 23;10(11):e0140627. doi: 10.1371/journal.pone.0140627. eCollection 2015.